Did you miss our expert panel discussion? ➡️ "Optimizing Clinical Trials at Health Systems: The Opportunity for AI" is available to watch now, on-demand. https://lnkd.in/eKqt9ZYU
Institute for Precision Medicine
Research Services
Pittsburgh, Pennsylvania 1,677 followers
A partnership of the University of Pittsburgh and UPMC
About us
The Institute for Precision Medicine (IPM) is a collaboration between the University of Pittsburgh and UPMC. The IPM facilitates the movement of biomedical research into personalized clinical care. The over-arching goal is to help researchers and clinicians discover and exploit clinically actionable individual features about risk of disease, optimal treatment, disease course, and response to treatment.
- Website
-
http://www.ipm.pitt.edu
External link for Institute for Precision Medicine
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Pittsburgh, Pennsylvania
- Type
- Educational
- Founded
- 2016
Locations
-
Primary
204 Craft Ave
Pittsburgh, Pennsylvania 15213, US
Employees at Institute for Precision Medicine
Updates
-
University of Pittsburgh Chancellor, Joan Gabel, and Carnegie Mellon University President, Farnam Jahanian, celebrated Pittsburgh’s role as an "AI Tech Community" by signing a ceremonial memorandum of understanding with NVIDIA at AI Horizons Pittsburgh on Oct. 14. The summit included keynote remarks from Pennsylvania Governor Josh Shapiro, discussing Pittsburgh’s global role in human-first AI innovation. “Pitt has extraordinary research strengths in life sciences and in learning sciences,” said Rob A. Rutenbar, Pitt’s senior vice chancellor for research. “Our new NVIDIA partnership gives us access to state-of-the-art AI technologies applicable across the full spectrum of our world-leading ‘meds and eds’ research.” https://lnkd.in/eZWSzDhG
-
Pitt Research sheds light on the correlation cholesterol and Alzheimer's disease in women. “We were able to show that as early as midlife, women who have more of the smaller-sized particles and those whose particles’ concentrations of phospholipids increased over the menopause transition are more likely to experience better episodic memory later in life,” said research team lead, Samar El Khoudary, professor of epidemiology in the University of Pittsburgh School of Public Health, adding that loss of working memory is the first sign of Alzheimer’s disease. Learn more ➡️ https://lnkd.in/efVuwsZ8 #WomensHealth #PrecisionMedicine
A recent Pitt study sheds light on the correlation between cholesterol and Alzheimer’s disease in women
pitt.edu
-
Adrian Lee, PhD, Director of the Institute for Precision Medicine, highlighted the critical role of clinical trials in integrating #PrecisionMedicine into clinical care during the opening of the “Optimizing Clinical Trials at Health Systems: The Opportunity for AI” expert panel discussion on Thursday, Oct. 3. 💡While acknowledging AI's vast potential, Dr. Lee noted the challenges it poses, but expressed optimism that AI could help overcome these hurdles. ➡️ Available Now: Discussion Recap🔗https://lnkd.in/ejdEq2jU
-
UPMC Enterprises hosted a panel during the AI Horizons Pittsburgh Summit yesterday on "AI Avenue" at Bakery Square. The panel highlighted AI-driven #healthcare and was moderated by Dr. Deepan C Kamaraj, Director of Analytics & Informatics, UPMC Enterprises. Learn more about the event and Pittsburgh as a new 'AI tech community' ⤵️ https://lnkd.in/e4fb5Wcs
📍 The AI Horizons Pittsburgh Summit is live now at UPMC Enterprises ⤵️ Dr. Deepan C Kamaraj, Director of Analytics & Informatics, UPMC Enterprises is leading the “AI-Driven Healthcare: Innovations and Ethics Shaping the Future of Wellness” panel with Dr. Suresh Mulukutla (Vice President and Chief Data and Analytics Officer, UPMC), Dr. Hooman H. Rashidi, MD, MS, FCAP (Associate Dean for AI in Medicine, University of Pittsburgh School of Medicine), and Russell Schwartz (Professor and Head of Computational Biology, Carnegie Mellon University). 💡The distinguished panelists are addressing key ethical considerations, such as data protection and patient privacy in addition to highlighting UPMC Enterprises’ Data Platform as a Service (DPaaS) initiative, which empowers #innovators and startups by providing access to de-identified datasets and advanced AI tools, driving breakthroughs in healthcare. https://lnkd.in/ei5x4Mia
-
Integrating #AI into the clinical trials process presents challenges, but the potential benefits are immense. AI can create a more efficient, equitable, and effective clinical trial process, accelerating new treatment developments and advancing #personalizedmedicine. Our recent panel discussion, “Optimizing Clinical Trials at Health Systems: The Opportunity for AI,” highlights the crucial role of #ClinicalTrials plays to integrate precision medicine into personalized care. 💡Watch the discussion here: https://lnkd.in/eKqt9ZYU
-
Dr. Mylynda Massart, Associate Director of IPM, will be speaking on the topic “Barriers to Access and Ecosystem Enablers of Health Equity” during a panel at the University of Pittsburgh Health Sciences and Business Conference on October 25th at 10:30 AM ET. For more details, you can visit the conference website. ⤵️
As a part of our health sciences and business conference, experts will discuss barriers to access and ecosystem enablers of health equity. Join this riveting discussion by registering today! https://bit.ly/3WVHJ9L
-
We are thrilled to announce our sponsorship of the upcoming Advancing Precision Medicine (APM) Conference, taking place on November 1-2, 2024. IPM Director, Adrian Lee, will lead the panel “Liquid Biopsy MRD to Escalate or De-escalate Therapy” on November 2nd. The panel will include esteemed speakers Marija Balic (UPMC) and Muhammed Murtaza (University of Wisconsin-Madison). APM will highlight a wide range of topics, including Precision Oncology, AI & Data Sciences, Genomics, NGS, Multi-Omics, Liquid Biopsy, CDx, Cell & Gene Therapy, Precision Pathology, MRD, Rare Disease, Clinical Trials, Reimbursement, Cardiovascular Disease, and Emerging Technologies. For more details about the event, visit: https://lnkd.in/e4NkDvki Let us know if you'll be there in the comments! ⤵️
-
Dr. James Coons, cardiology pharmacotherapy specialist and clinical researcher at the University of Pittsburgh, was recently published in Oxford Academic for his research. A newly proposed model integrates clinical pharmacists into patient care teams, enhancing medication management and patient outcomes. This initiative underscores the vital role of pharmacist-led education and training. Discover how this innovative approach is transforming patient care. 🏥💊 https://lnkd.in/ebsDskuk
-
Live Now ➡️ Experts from the Institute for Precision Medicine (Adrian Lee) UPMC (Nicole Ansani), Realyze Intelligence (Aaron Brauser), CSIRO's Data61 (Stefan Harrer, PhD), and University of Nebraska Medical Center (Matthew Lunning) are discussing, "Optimizing Clinical Trials at Health Systems: The Opportunity for AI." 💡It isn't too late to be part of the conversation, link to join: https://lnkd.in/eKqt9ZYU